記住我
Uncertainty exists regarding the risks of adverse pregnancy outcomes for patients with axial spondyloarthritis (axSpA), owing to a lack of high-quality evidence. Reassuringly, however, the results of a large register-based cohort study highlight that pregnancy outcomes have improved over time, in parallel with the increased use of biologic DMARDs during pregnancy.
留言 (0)